Meeting
2022 ASCO Annual Meeting
Acquired EGFR-resistant mutations in non–small cell lung cancer (NSCLC).
Authors
Luis E. Raez
Thoracic Oncology Program, Memorial Cancer Institute/Florida Atlantic University, Miami, FL
Luis E. Raez , Yasmine Baca , Jorge J. Nieva , Hirva Mamdani , Gilberto Lopes , Hossein Borghaei , Mark A. Socinski , Chadi Nabhan , Antoinette J. Wozniak , Ari M. Vanderwalde , Carlos Carracedo Uribe , Hina Khan , Stephen V. Liu , Misako Nagasaka
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Lung Cancer—Non-Small Cell Metastatic
Track
Lung Cancer
Sub Track
Biologic Correlates
Citation
J Clin Oncol 40, 2022 (suppl 16; abstr 9113)
DOI
10.1200/JCO.2022.40.16_suppl.9113
Abstract #
9113
Poster Bd #
99
Abstract Disclosures
Similar Posters
Poster
2021 ASCO Annual Meeting
Targeted ctDNA sequencing analysis reveals concurrent genomic alterations and its impact on TKI and immune checkpoint inhibitor therapy in advanced NSCLC from Asian population.
First Author: Wei Wu
Poster
2016 ASCO Annual Meeting
Genetic heterogeneity of KRAS-mutated NSCLC: Co-occurrence of potentially targetable aberrations and evolutionary background.
First Author: Matthias Scheffler
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of pancreatic cancer (PC): KRAS wild type vs. KRAS mutant tumors and primary tumors vs. distant metastases.
First Author: Mohamed E. Salem
Poster
2016 ASCO Annual Meeting
Comparative molecular analyses of BRAF-V600E mutant tumors: Colorectal cancers (CRC) vs. melanomas.
First Author: Shelly Ann Christiansen